JP2021508236A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2021508236A5 JP2021508236A5 JP2020527921A JP2020527921A JP2021508236A5 JP 2021508236 A5 JP2021508236 A5 JP 2021508236A5 JP 2020527921 A JP2020527921 A JP 2020527921A JP 2020527921 A JP2020527921 A JP 2020527921A JP 2021508236 A5 JP2021508236 A5 JP 2021508236A5
- Authority
- JP
- Japan
- Prior art keywords
- human animal
- trkb
- endogenous
- seq
- human
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 102100035080 BDNF/NT-3 growth factors receptor Human genes 0.000 claims description 54
- 101000596896 Homo sapiens BDNF/NT-3 growth factors receptor Proteins 0.000 claims description 54
- 101100517383 Homo sapiens NTRK2 gene Proteins 0.000 claims description 39
- 238000000034 method Methods 0.000 claims description 39
- 230000001086 cytosolic effect Effects 0.000 claims description 29
- 108091026890 Coding region Proteins 0.000 claims description 24
- 108010076504 Protein Sorting Signals Proteins 0.000 claims description 20
- 230000008685 targeting Effects 0.000 claims description 19
- 101150056950 Ntrk2 gene Proteins 0.000 claims description 14
- 239000003153 chemical reaction reagent Substances 0.000 claims description 12
- 210000001161 mammalian embryo Anatomy 0.000 claims description 9
- 210000004102 animal cell Anatomy 0.000 claims description 7
- 230000000324 neuroprotective effect Effects 0.000 claims description 7
- 102000005937 Tropomyosin Human genes 0.000 claims description 6
- 108010030743 Tropomyosin Proteins 0.000 claims description 6
- 239000000556 agonist Substances 0.000 claims description 6
- 210000004027 cell Anatomy 0.000 claims description 6
- 230000003833 cell viability Effects 0.000 claims description 6
- 108020004707 nucleic acids Proteins 0.000 claims description 6
- 102000039446 nucleic acids Human genes 0.000 claims description 6
- 150000007523 nucleic acids Chemical class 0.000 claims description 6
- 210000003994 retinal ganglion cell Anatomy 0.000 claims description 6
- 108090000623 proteins and genes Proteins 0.000 claims description 5
- 241001465754 Metazoa Species 0.000 claims description 4
- 102000025171 antigen binding proteins Human genes 0.000 claims description 4
- 108091000831 antigen binding proteins Proteins 0.000 claims description 4
- 230000000694 effects Effects 0.000 claims description 4
- 230000004060 metabolic process Effects 0.000 claims description 4
- 210000001328 optic nerve Anatomy 0.000 claims description 4
- 150000003384 small molecules Chemical group 0.000 claims description 4
- 208000030768 Optic nerve injury Diseases 0.000 claims description 3
- 238000002266 amputation Methods 0.000 claims description 3
- 230000037396 body weight Effects 0.000 claims description 3
- 238000004519 manufacturing process Methods 0.000 claims description 3
- 102000043136 MAP kinase family Human genes 0.000 claims description 2
- 108091054455 MAP kinase family Proteins 0.000 claims description 2
- 241000124008 Mammalia Species 0.000 claims description 2
- 108091007960 PI3Ks Proteins 0.000 claims description 2
- 241000283984 Rodentia Species 0.000 claims description 2
- 230000004913 activation Effects 0.000 claims description 2
- 210000000577 adipose tissue Anatomy 0.000 claims description 2
- 235000012631 food intake Nutrition 0.000 claims description 2
- 102000006261 human tropomyosin-related kinase-B Human genes 0.000 claims description 2
- 108010058135 human tropomyosin-related kinase-B Proteins 0.000 claims description 2
- 238000001727 in vivo Methods 0.000 claims description 2
- 230000033001 locomotion Effects 0.000 claims description 2
- 230000037361 pathway Effects 0.000 claims description 2
- 230000026731 phosphorylation Effects 0.000 claims description 2
- 238000006366 phosphorylation reaction Methods 0.000 claims description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 2
- 108091005682 Receptor kinases Proteins 0.000 claims 3
- 102000004169 proteins and genes Human genes 0.000 claims 3
- 102000038030 PI3Ks Human genes 0.000 claims 1
- 108020005004 Guide RNA Proteins 0.000 description 8
- 241000699670 Mus sp. Species 0.000 description 6
- 101710163270 Nuclease Proteins 0.000 description 4
- 241000700159 Rattus Species 0.000 description 4
- 239000003795 chemical substances by application Substances 0.000 description 4
- 230000008439 repair process Effects 0.000 description 4
- 108091033409 CRISPR Proteins 0.000 description 2
- 241000699666 Mus <mouse, genus> Species 0.000 description 2
- 210000002257 embryonic structure Anatomy 0.000 description 2
- 102000010400 1-phosphatidylinositol-3-kinase activity proteins Human genes 0.000 description 1
- 238000003776 cleavage reaction Methods 0.000 description 1
- 210000001525 retina Anatomy 0.000 description 1
- 230000007017 scission Effects 0.000 description 1
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2023171306A JP7610672B2 (ja) | 2017-11-30 | 2023-10-02 | ヒト化ｔｒｋｂ遺伝子座を含む非ヒト動物 |
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201762592905P | 2017-11-30 | 2017-11-30 | |
| US62/592,905 | 2017-11-30 | ||
| US201862661373P | 2018-04-23 | 2018-04-23 | |
| US62/661,373 | 2018-04-23 | ||
| PCT/US2018/063390 WO2019108983A1 (en) | 2017-11-30 | 2018-11-30 | Non-human animals comprising a humanized trkb locus |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023171306A Division JP7610672B2 (ja) | 2017-11-30 | 2023-10-02 | ヒト化ｔｒｋｂ遺伝子座を含む非ヒト動物 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2021508236A JP2021508236A (ja) | 2021-03-04 |
| JP2021508236A5 true JP2021508236A5 (https=) | 2021-12-16 |
| JP7361031B2 JP7361031B2 (ja) | 2023-10-13 |
Family
ID=64734209
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020527921A Active JP7361031B2 (ja) | 2017-11-30 | 2018-11-30 | ヒト化ｔｒｋｂ遺伝子座を含む非ヒト動物 |
| JP2023171306A Active JP7610672B2 (ja) | 2017-11-30 | 2023-10-02 | ヒト化ｔｒｋｂ遺伝子座を含む非ヒト動物 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023171306A Active JP7610672B2 (ja) | 2017-11-30 | 2023-10-02 | ヒト化ｔｒｋｂ遺伝子座を含む非ヒト動物 |
Country Status (11)
| Country | Link |
|---|---|
| US (2) | US11419318B2 (https=) |
| EP (2) | EP4299732A3 (https=) |
| JP (2) | JP7361031B2 (https=) |
| KR (1) | KR102709884B1 (https=) |
| CN (2) | CN111655031B (https=) |
| AU (2) | AU2018375796B2 (https=) |
| CA (1) | CA3076377A1 (https=) |
| ES (1) | ES2973937T3 (https=) |
| IL (2) | IL310006A (https=) |
| SG (1) | SG11202002456WA (https=) |
| WO (1) | WO2019108983A1 (https=) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IL310006A (en) | 2017-11-30 | 2024-03-01 | Regeneron Pharma | Non-human animals containing a humanized TRKB locus |
| KR20250121150A (ko) | 2018-03-26 | 2025-08-11 | 리제너론 파마슈티칼스 인코포레이티드 | 치료제를 시험하기 위한 인간화된 설치류 |
| IL278267B2 (en) | 2018-07-16 | 2025-02-01 | Regeneron Pharma | Non-human animal models of DITRA disease and their uses |
| JP7524158B2 (ja) * | 2019-03-04 | 2024-07-29 | 公益財団法人東京都医学総合研究所 | Ｔｒｋ断片をコードする核酸構築物、及びその利用 |
| EP4099821A1 (en) * | 2020-02-07 | 2022-12-14 | Regeneron Pharmaceuticals, Inc. | <smallcaps/>? ? ?klkb1? ? ? ? ?non-human animals comprising a humanizedlocus and methods of use |
Family Cites Families (57)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5523226A (en) | 1993-05-14 | 1996-06-04 | Biotechnology Research And Development Corp. | Transgenic swine compositions and methods |
| US5877016A (en) * | 1994-03-18 | 1999-03-02 | Genentech, Inc. | Human trk receptors and neurotrophic factor inhibitors |
| AU8587598A (en) | 1997-07-26 | 1999-02-16 | Wisconsin Alumni Research Foundation | Trans-species nuclear transfer |
| AU2001273245A1 (en) | 2000-07-05 | 2002-01-14 | Pangene Corporation | Modulators of trk protein activity, compositions and uses |
| US6586251B2 (en) | 2000-10-31 | 2003-07-01 | Regeneron Pharmaceuticals, Inc. | Methods of modifying eukaryotic cells |
| US20050144655A1 (en) | 2000-10-31 | 2005-06-30 | Economides Aris N. | Methods of modifying eukaryotic cells |
| US7060429B2 (en) * | 2001-02-22 | 2006-06-13 | University Of Maryland, Baltimore | Treatment of neurodegenerative diseases by altering levels of TrkB isoforms and/or TrkC isoforms |
| AUPR451401A0 (en) | 2001-04-20 | 2001-05-24 | Monash University | A method of nuclear transfer |
| US7612250B2 (en) | 2002-07-29 | 2009-11-03 | Trustees Of Tufts College | Nuclear transfer embryo formation method |
| US7250496B2 (en) * | 2002-11-14 | 2007-07-31 | Rosetta Genomics Ltd. | Bioinformatically detectable group of novel regulatory genes and uses thereof |
| AU2005295269B2 (en) | 2004-10-19 | 2010-05-13 | Regeneron Pharmaceuticals, Inc. | Method for generating an animal homozygous for a genetic modification |
| CN101117633B (zh) | 2006-08-03 | 2011-07-20 | 上海交通大学附属儿童医院 | 一种细胞核移植方法 |
| CN101157730A (zh) | 2006-09-25 | 2008-04-09 | 南方医科大学珠江医院 | 一种携带神经营养因子穿过血脑屏障的融合蛋白及其编码基因与用途 |
| MX2010004494A (es) * | 2007-10-23 | 2010-08-30 | Novartis Ag | Uso de anticuerpos de trkb para el tratamiento de trastornos respiratorios. |
| WO2009126161A1 (en) | 2008-04-11 | 2009-10-15 | Utc Fuel Cells, Llc | Fuel cell and bipolar plate having manifold sump |
| JP5816170B2 (ja) | 2009-06-26 | 2015-11-18 | リジェネロン・ファーマシューティカルズ・インコーポレイテッドＲｅｇｅｎｅｒｏｎ Ｐｈａｒｍａｃｅｕｔｉｃａｌｓ， Ｉｎｃ． | 天然の免疫グロブリン形式を有する容易に単離される二重特異性抗体 |
| RU2425880C2 (ru) | 2009-07-30 | 2011-08-10 | Учреждение Российской академии наук Институт общей генетики им. Н.И. Вавилова РАН | Способ получения трансгенных мышей |
| WO2011020005A1 (en) | 2009-08-14 | 2011-02-17 | Regeneron Pharmaceuticals, Inc. | miRNA-REGULATED DIFFERENTIATION-DEPENDENT SELF-DELETING CASSETTE |
| EP2494047B1 (en) | 2009-10-29 | 2017-01-04 | Regeneron Pharmaceuticals, Inc. | Multifunctional alleles |
| WO2013063556A1 (en) | 2011-10-28 | 2013-05-02 | Regeneron Pharmaceuticals, Inc. | Humanized il-6 and il-6 receptor |
| DK3590332T3 (da) | 2011-10-28 | 2022-05-23 | Regeneron Pharma | Genmodificerede mus, der eksprimerer kimære major histokompatibilitetskompleks (MHC) II-molekyler |
| SI2770821T1 (en) | 2011-10-28 | 2018-01-31 | Regeneron Pharmaceuticals, Inc. | Genetically modified major histocompatibility complex of mice |
| IN2014DN09261A (https=) | 2012-04-25 | 2015-07-10 | Regeneron Pharma | |
| EP3241902B1 (en) | 2012-05-25 | 2018-02-28 | The Regents of The University of California | Methods and compositions for rna-directed target dna modification and for rna-directed modulation of transcription |
| WO2014033644A2 (en) | 2012-08-28 | 2014-03-06 | Novartis Ag | Methods of nuclease-based genetic engineering |
| CA2887706C (en) | 2012-11-05 | 2022-08-02 | Regeneron Pharmaceuticals | Genetically modified non-human animals and methods of use thereof |
| EP3363902B1 (en) | 2012-12-06 | 2019-11-27 | Sigma Aldrich Co. LLC | Crispr-based genome modification and regulation |
| MX2015010841A (es) | 2013-02-20 | 2016-05-09 | Regeneron Pharma | Modificacion genetica de ratas. |
| KR102714111B1 (ko) | 2013-02-20 | 2024-10-11 | 리제너론 파아마슈티컬스, 인크. | 사람화된 ｔ-세포 보조-수용체를 발현하는 마우스 |
| PL2958937T3 (pl) | 2013-02-22 | 2019-01-31 | Regeneron Pharmaceuticals, Inc. | Myszy ekspresjonujące humanizowany główny układ zgodności tkankowej |
| US20150342163A1 (en) | 2013-02-22 | 2015-12-03 | Regeneron Pharmaceuticals, Inc. | Genetically modified major histocompatibility complex mice |
| SI2986729T1 (sl) | 2013-04-16 | 2019-02-28 | Regeneron Pharmaceuticals, Inc. | Ciljana sprememba genoma podgane |
| CN105592695B (zh) | 2013-09-23 | 2018-04-10 | 瑞泽恩制药公司 | 具有人源化信号调节蛋白基因的非人动物 |
| CA2929846C (en) | 2013-11-19 | 2020-09-15 | Regeneron Pharmaceuticals, Inc. | Non-human animals having a humanized b-cell activating factor gene |
| SG10201811701YA (en) | 2013-11-19 | 2019-01-30 | Regeneron Pharma | Non-human animals having a humanized a proliferation-inducing ligand gene |
| US9546384B2 (en) | 2013-12-11 | 2017-01-17 | Regeneron Pharmaceuticals, Inc. | Methods and compositions for the targeted modification of a mouse genome |
| JP6618912B2 (ja) | 2013-12-20 | 2019-12-11 | エフ．ホフマン−ラ ロシュ アーゲーＦ． Ｈｏｆｆｍａｎｎ−Ｌａ Ｒｏｃｈｅ Ａｋｔｉｅｎｇｅｓｅｌｌｓｃｈａｆｔ | 改良された、組換えポリペプチド作製方法 |
| EP3107565A4 (en) * | 2014-02-21 | 2017-08-23 | Regeneron Pharmaceuticals, Inc. | Methods, compositions and kits for cell specific modulation of target antigens |
| HUE051088T2 (hu) | 2014-04-08 | 2021-03-01 | Regeneron Pharma | Humanizált FC-gamma receptorokkal rendelkezõ nem humán élõlények |
| NO2785538T3 (https=) | 2014-05-07 | 2018-08-04 | ||
| ES2936810T3 (es) * | 2014-05-16 | 2023-03-22 | Pfizer | Anticuerpos biespecíficos con interfaces CH1-CL de ingeniería |
| SG10202002187WA (en) | 2014-05-19 | 2020-04-29 | Regeneron Pharma | Genetically modified non-human animals expressing human epo |
| ES2783424T3 (es) | 2014-06-19 | 2020-09-17 | Regeneron Pharma | Animales no humanos que tienen un gen de muerte celular programada 1 humanizado |
| HUE049405T2 (hu) | 2014-06-23 | 2020-09-28 | Regeneron Pharma | Nukleáz-közvetített DNS-összeállítás |
| KR102386101B1 (ko) | 2014-06-26 | 2022-04-14 | 리제너론 파마슈티칼스 인코포레이티드 | 표적화된 유전자 변형을 위한 방법 및 그 조성물, 및 사용 방법 |
| EP3169309B1 (en) | 2014-07-16 | 2023-05-10 | Novartis AG | Method of encapsulating a nucleic acid in a lipid nanoparticle host |
| CA2959428A1 (en) * | 2014-09-19 | 2016-03-24 | Regeneron Pharmaceuticals, Inc. | Chimeric antigen receptors |
| ES2731437T3 (es) | 2014-11-21 | 2019-11-15 | Regeneron Pharma | Métodos y composiciones para la modificación genética dirigida mediante el uso de pares de ARN guías |
| RU2020122439A (ru) | 2014-11-24 | 2020-09-24 | Регенерон Фармасьютикалз, Инк. | Не относящиеся к человеку животные, экспрессирующие гуманизированный комплекс cd3 |
| SI3086637T1 (sl) * | 2014-12-05 | 2019-04-30 | Regeneron Pharmaceuticals, Inc. | Nehumane živali s humaniziranim označevalcem diferenciacije gena CD47 |
| HUE052606T2 (hu) | 2014-12-09 | 2021-05-28 | Regeneron Pharma | Humanizált differenciációs klaszter 274 génnel rendelkezõ nem humán állatok |
| CN113349159B (zh) | 2015-04-06 | 2022-11-11 | 瑞泽恩制药公司 | 非人动物中的人源化t细胞介导的免疫应答 |
| SG11201803409UA (en) * | 2015-11-20 | 2018-05-30 | Regeneron Pharma | Non-human animals having a humanized lymphocyte-activation gene 3 |
| WO2019108662A1 (en) * | 2017-11-30 | 2019-06-06 | Regeneron Pharmaceuticals, Inc. | Anti-trkb monoclonal antibodies and methods of use |
| IL310006A (en) | 2017-11-30 | 2024-03-01 | Regeneron Pharma | Non-human animals containing a humanized TRKB locus |
| KR20250121150A (ko) | 2018-03-26 | 2025-08-11 | 리제너론 파마슈티칼스 인코포레이티드 | 치료제를 시험하기 위한 인간화된 설치류 |
| IL278267B2 (en) | 2018-07-16 | 2025-02-01 | Regeneron Pharma | Non-human animal models of DITRA disease and their uses |
-
2018
- 2018-11-30 IL IL310006A patent/IL310006A/en unknown
- 2018-11-30 CA CA3076377A patent/CA3076377A1/en active Pending
- 2018-11-30 AU AU2018375796A patent/AU2018375796B2/en active Active
- 2018-11-30 EP EP23207807.1A patent/EP4299732A3/en active Pending
- 2018-11-30 KR KR1020207013978A patent/KR102709884B1/ko active Active
- 2018-11-30 EP EP18821882.0A patent/EP3585164B1/en active Active
- 2018-11-30 JP JP2020527921A patent/JP7361031B2/ja active Active
- 2018-11-30 SG SG11202002456WA patent/SG11202002456WA/en unknown
- 2018-11-30 IL IL274740A patent/IL274740B2/en unknown
- 2018-11-30 WO PCT/US2018/063390 patent/WO2019108983A1/en not_active Ceased
- 2018-11-30 US US16/206,330 patent/US11419318B2/en active Active
- 2018-11-30 CN CN201880087972.5A patent/CN111655031B/zh active Active
- 2018-11-30 ES ES18821882T patent/ES2973937T3/es active Active
- 2018-11-30 CN CN202211340155.0A patent/CN116064611A/zh active Pending
-
2022
- 2022-06-30 US US17/810,029 patent/US12396444B2/en active Active
-
2023
- 2023-10-02 JP JP2023171306A patent/JP7610672B2/ja active Active
-
2025
- 2025-02-07 AU AU2025200858A patent/AU2025200858A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2021508236A5 (https=) | ||
| JP6600061B2 (ja) | ヒト化ｉｌ−１５動物 | |
| US20200022342A1 (en) | Genetically Modified Non-Human Animal With Human Or Chimeric PD-L1 | |
| JP2021505187A (ja) | 遺伝子編集のためのｃｐｆ１関連方法及び組成物 | |
| CN111549072B (zh) | Vista基因人源化动物细胞及动物模型的构建方法与应用 | |
| CA3179113A1 (en) | Selection and monitoring methods for xenotransplantation | |
| JP2020108409A (ja) | ｌｉｎｃＲＮＡ欠失非ヒト動物 | |
| IL274740B2 (en) | Non-human animals comprising a humanized trkb locus | |
| IL319209A (en) | Non-human animals containing a humanized ASGR1 locus | |
| EP2135951A1 (en) | Transgenic rodents having ngf beta gene mutants and its preparation methods, the preparation methods of the corresponding mutant proteins and the resulting mutant proteins | |
| AU737678B2 (en) | Transgenic animal with recombinant vascular endothelial growth factor B (VEGF-B) DNA and uses thereof | |
| CN111019972A (zh) | 一种cd27人源化小鼠模型的构建方法及其应用 | |
| CN108024522A (zh) | Etv2及其用途 | |
| JP2018522553A5 (https=) | ||
| US20230172170A1 (en) | Non-human animals having a humanized cxcl13 gene | |
| JP2008501357A5 (https=) | ||
| CN114592011B (zh) | 一种ptdss2条件性基因敲除小鼠模型的构建方法 | |
| JP2018523999A5 (https=) | ||
| CN117210497A (zh) | Abcg4基因在构建脑动脉粥样硬化伴肺部增大小鼠模型中的应用 | |
| WO2013056664A1 (zh) | 家蚕丝素重链基因突变序列及突变的方法和应用 | |
| Hu et al. | A perspective on fish gonad manipulation for biotechnical applications | |
| JP2018520682A5 (https=) | ||
| CN116058335B (zh) | 一种自发强直性脊柱炎模型的构建方法和应用 | |
| WO2021159741A1 (zh) | 一种用于制备irs基因缺陷的糖尿病克隆猪核供体细胞的crispr系统及其应用 | |
| JP6267785B2 (ja) | Ｃｍｐ−アセチルノイラミン酸ヒドロキシラーゼタゲッティングベクター、そのベクターが導入された異種間移植用形質転換動物及びその製造方法 |